TLPH Q1 2018 Earnings — Talphera, Inc. Revenue & Financial Results | Market Cap Arena

TLPHTalphera, Inc.

$18M

Q1 2018 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$343,000-89.0% YoY

Gross Profit

-$4M-1249.0% margin

Operating Income

-$8M-2410.8% margin

Net Income

-$12M-3379.6% margin

EPS (Diluted)

$-4.55

QoQ Revenue Growth

-53.6%

Cash Flow

Operating Cash Flow

-$7M

Free Cash Flow

-$8M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$66M

Total Liabilities

$113M

Stockholders' Equity

-$47M

Cash & Equivalents

$44M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$343,000	$3M	-89.0%
Gross Profit	-$4M	-$8M	+46.0%
Operating Income	-$8M	-$12M	+31.5%
Net Income	-$12M	-$16M	+25.5%